Browse by UCL people
Group by: Type | Date
Number of items: 6.
Article
Camilleri, M;
Sive, J;
Wilson, W;
Pang, G;
Jenner, R;
Phillips, E;
Popat, R;
... Yong, K; + view all
(2021)
COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial.
British Journal of Haematology
, 192
(1)
E14-E16.
10.1111/bjh.17168.
|
|
Camilleri, Marquita;
Bekris, Georgios;
Sidhu, Govundeep;
Buck, Caroline;
Elsden, Esma;
McCourt, Orla;
Horder, Jackie;
... Fisher, Abigail; + view all
(2022)
The impact of COVID-19 on autologous stem cell transplantation in multiple myeloma: A single-centre, qualitative evaluation study.
Supportive Care in Cancer
10.1007/s00520-022-07173-5.
(In press).
|
|
Camilleri, M;
Cuadrado, M;
Phillips, E;
Wilson, W;
Jenner, R;
Pang, G;
Kamora, S;
... Yong, K; + view all
(2021)
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.
British Journal of Haematology
10.1111/bjh.17377.
(In press).
|
 |
|
Melotti, Dario;
Asher, Samir;
Troy-Barnes, Ethan;
Nesr, George;
Wilson, William;
Camilleri, Marquita;
Popat, Rakesh;
... Kyriakou, Chara; + view all
(2024)
Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co-morbidities: Single-centre experience.
eJHaem
, 5
(5)
10.1002/jha2.977.
|
|
|
Yong, K;
Wilson, W;
de Tute, RM;
Camilleri, M;
Ramasamy, K;
Streetly, M;
Sive, J;
... Popat, R; + view all
(2022)
Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib–cyclophosphamide–dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial.
The Lancet Haematology
, 10
(2)
e93-e106.
10.1016/S2352-3026(22)00350-7.
|
Thesis
|
Camilleri, Marquita;
(2024)
The Role of Autologous Stem Cell Transplantation in High-Risk Multiple Myeloma in the Novel Agent Era.
Doctoral thesis (M.D(Res)), UCL (University College London).
|
|
